Mitochondrial reactive oxygen species accelerate the expression of heme carrier protein 1 and enhance photodynamic cancer therapy effect
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 55 (1) , 67-71
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 24 references indexed in Scilit:
- Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy Selectively Kills Sarcomas by Inducing ApoptosisPLOS ONE, 2013
- Mitochondrial reactive oxygen species drive proinflammatory cytokine productionJournal of Experimental Medicine, 2011
- The Obligatory Intestinal Folate Transporter PCFT (SLC46A1) Is Regulated by Nuclear Respiratory Factor 1Journal of Biological Chemistry, 2010
- 99mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imagingJournal of Materials Chemistry, 2010
- Mechanisms associated with mitochondrial-generated reactive oxygen species in cancerThis article is one of a selection of papers published in a Special Issue on Oxidative Stress in Health and Disease.Canadian Journal of Physiology and Pharmacology, 2010
- The role of transporters in cellular heme and porphyrin homeostasisPharmacology & Therapeutics, 2007
- Haem carrier protein 1 (HCP1): Expression and functional studies in cultured cellsFEBS Letters, 2006
- Identification of an Intestinal Heme TransporterCell, 2005
- Tumor Necrosis Factor-α-Induced Cytokine-Induced Neutrophil Chemoattractant-1 (CINC-1) Production by Rat Gastric Epithelial Cells: Role of Reactive Oxygen Species and Nuclear Factor-κBThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tractSeminars in Surgical Oncology, 1985